Romiplostim for the treatment of chronic immune thrombocytopenia

Technology appraisal guidance
Reference number: TA221
Published: 27 April 2011
Last updated: 26 October 2018

Thrombocytopenic purpura - romiplostim: final appraisal determination

Thrombocytopenic purpura - romiplostim: final appraisal determination

Thrombocytopenic purpura - romiplostim: final appraisal determination
17 March 2011
(251.65 Kb 13 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 15 March 2011